The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease ; volume:22 ; number:1 ; day:12 ; month:1 ; year:2024 ; pages:1-19 ; date:12.2024
Cell communication and signaling ; 22, Heft 1 (12.1.2024), 1-19, 12.2024
- Creator
-
Miao, Yongzhen
Meng, Hongrui
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-023-01402-y
- URN
-
urn:nbn:de:101:1-2024032515292204239500
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Miao, Yongzhen
- Meng, Hongrui
- SpringerLink (Online service)
Other Objects (12)
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Hypoxia inducible factor-1α regulates microglial innate immune memory and the pathology of Parkinson’s disease
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Definition and diagnosis of Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
The psychometric properties of the Chinese version of the Parkinson Anxiety Scale (C-PAS) among Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease
Tau in the Pathophysiology of Parkinson’s Disease
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Hypoxia inducible factor-1α regulates microglial innate immune memory and the pathology of Parkinson’s disease
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Definition and diagnosis of Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
The psychometric properties of the Chinese version of the Parkinson Anxiety Scale (C-PAS) among Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease
Tau in the Pathophysiology of Parkinson’s Disease
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Hypoxia inducible factor-1α regulates microglial innate immune memory and the pathology of Parkinson’s disease
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Definition and diagnosis of Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
The psychometric properties of the Chinese version of the Parkinson Anxiety Scale (C-PAS) among Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease